These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. GABAA receptors in the central nucleus of amygdala (CeA) affect on pain modulation. Hasanein P, Mirazi N, Javanmardi K. Brain Res; 2008 Nov 19; 1241():36-41. PubMed ID: 18838064 [Abstract] [Full Text] [Related]
4. Muscimol, gamma-aminobutyric acidA receptors and excitatory amino acids in the mouse spinal cord. Aanonsen LM, Wilcox GL. J Pharmacol Exp Ther; 1989 Mar 19; 248(3):1034-8. PubMed ID: 2467978 [Abstract] [Full Text] [Related]
5. Spinally mediated antinociception following intrathecal chlordiazepoxide--further evidence for a benzodiazepine spinal analgesic effect. Boulter N, Serrao JM, Gent JP, Goodchild CS. Eur J Anaesthesiol; 1991 Sep 19; 8(5):407-11. PubMed ID: 1657599 [Abstract] [Full Text] [Related]
6. Reversal by naloxone of spinal antinociceptive effects of fentanyl, ketocyclazocine and midazolam. Serrao JM, Goodchild CS, Gent JP. Eur J Anaesthesiol; 1991 Sep 19; 8(5):401-6. PubMed ID: 1657598 [Abstract] [Full Text] [Related]
7. Oxysophoridine through intrathecal injection induces antinociception and increases the expression of the GABAAα1 receptor in the spinal cord of mice. Yang G, Gao J, Jia Y, Yan L, Yu J, Jiang Y. Planta Med; 2012 Jun 19; 78(9):874-80. PubMed ID: 22532023 [Abstract] [Full Text] [Related]
9. Involvement of GABAergic modulation of antinociception induced by morphine microinjected into the ventrolateral orbital cortex. Qu CL, Tang JS, Jia H. Brain Res; 2006 Feb 16; 1073-1074():281-9. PubMed ID: 16448630 [Abstract] [Full Text] [Related]
10. Interaction between midazolam and serotonin in spinally mediated antinociception in rats. Nishiyama T. J Anesth; 2009 Feb 16; 23(2):249-55. PubMed ID: 19444565 [Abstract] [Full Text] [Related]
11. Serotonin modifies the neuronal inhibitory responses to gamma-aminobutyric acid in the red nucleus: a microiontophoretic study in the rat. Licata F, Li Volsi G, Di Mauro M, Fretto G, Ciranna L, Santangelo F. Exp Neurol; 2001 Jan 16; 167(1):95-107. PubMed ID: 11161597 [Abstract] [Full Text] [Related]
12. Role of benzodiazepine and serotonergic mechanisms in conditioned freezing and antinociception using electrical stimulation of the dorsal periaqueductal gray as unconditioned stimulus in rats. Castilho VM, Macedo CE, Brandão ML. Psychopharmacology (Berl); 2002 Dec 16; 165(1):77-85. PubMed ID: 12474121 [Abstract] [Full Text] [Related]
13. Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. Dirig DM, Yaksh TL. J Pharmacol Exp Ther; 1995 Oct 16; 275(1):219-27. PubMed ID: 7562553 [Abstract] [Full Text] [Related]
14. [The action of GABA agonists and an antagonist on the frequency structure of the electrical activity of different brain formations in rats]. Iarkov AV, Vorob'ev VV, Kovalev GI. Fiziol Zh SSSR Im I M Sechenova; 1991 Nov 16; 77(11):12-20. PubMed ID: 1668661 [Abstract] [Full Text] [Related]
15. Antinociceptive role of 5-HT1A receptors in rat spinal cord. Nadeson R, Goodchild CS. Br J Anaesth; 2002 May 16; 88(5):679-84. PubMed ID: 12067006 [Abstract] [Full Text] [Related]
16. Involvement of GABAergic modulation of the nucleus submedius (Sm) morphine-induced antinociception. Jia H, Xie YF, Xiao DQ, Tang JS. Pain; 2004 Mar 16; 108(1-2):28-35. PubMed ID: 15109504 [Abstract] [Full Text] [Related]
17. Involvement of GABA A receptor-associated chloride channels in the peripheral antinociceptive effect induced by GABA A receptor agonist muscimol. Reis G, Pacheco D, Francischi J, Castro M, Perez A, Duarte I. Eur J Pharmacol; 2007 Jun 14; 564(1-3):112-5. PubMed ID: 17445797 [Abstract] [Full Text] [Related]
18. GABAergic modulation mediates antinociception produced by serotonin applied into thalamic nucleus submedius of the rat. Xiao DQ, Zhu JX, Tang JS, Jia H. Brain Res; 2005 Sep 28; 1057(1-2):161-7. PubMed ID: 16125153 [Abstract] [Full Text] [Related]
19. [Antinociceptive effects of intrathecally administered GABA agonists at the spinal cord level]. Yamada Y, Saito Y, Hara K, Kirihara Y, Doi K, Kosaka Y. Masui; 1999 Jun 28; 48(6):605-10. PubMed ID: 10402811 [Abstract] [Full Text] [Related]